Advertisement
Home Tags Cancer: Leukemia

Tag: Cancer: Leukemia

Researchers are zeroing in on factors that may increase the risk of leukemia after breast cancer treatment

Etiology of Leukemia in Breast Cancer Survivors Explored

0
Family history of cancer, inherited gene mutation seem to raise chances of secondary malignancy
Excess relative risk of computed tomography scans for quantification of cystic fibrosis can be calculated

Excess Relative Risk of Repeat CT Scans Can Be Quantified

0
Recent publication demonstrates that very low doses repeated over time as harmful as acute exposure
For children

Residential Pesticide Exposure May Raise Childhood Cancer Risk

0
Increased risk of childhood leukemia and lymphoma seen with indoor insecticide exposure
For patients with relapsed or refractory hairy-cell leukemia

Vemurafenib Deemed Highly Effective in Hairy-Cell Leukemia

0
Findings from two phase 2 studies in Italy and United States show short oral course is highly effective
An experimental therapy for chronic lymphocytic leukemia that uses a patient's own T cells (an approach known as CTL019) may cure some patients and prolong survival in others

Long-Term Remissions of CLL in First Personalized Cell Tx Trial

0
T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells
Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to nearly five years in a study published online Sept. 2 in Nature.

Addition of Glitazone to Chemo May Help Treat CML

0
Combining glitazones with standard treatment improved survival in small study
Older patients with acute myeloid leukemia are intense users of health care services and rarely use palliative care and hospice services

Older Cancer Patients Heavily Use Health Care Services

0
Regardless of chemo intensity, palliative care, hospice rarely used with acute myeloid leukemia
For adult patients with de novo acute myeloid leukemia

Genomic Approach Could Aid Risk Stratification in Adults With AML

0
Persistent leukemia-linked mutations in remission samples tied to increased relapse, worse survival
Medicare will pay for a new

Medicare Will Cover Expensive New Leukemia Medication

0
Amgen's Blincyto costs about $178,000 for a standard course of treatment
Tyrosine kinase inhibitors appear to be safe in patients with chronic-phase chronic myeloid leukemia and chronic kidney disease

Tyrosine Kinase Inhibitors Seem Safe in CML With CKD

0
In these patients, no further decline in GFR, regardless of TKI used